Dicot Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	592	617	431	260	46	71
Market Cap Growth	12.01%	43.01%	65.92%	464.37%	-35.49%	56.49%
Enterprise Value	582	603	421	215	32	54
Last Close Price	0.29	0.31	0.24	0.32	0.34	0.69
PB Ratio	8.06	8.40	3.86	5.86	8.60	2.52
P/TBV Ratio	8.06	8.40	3.86	5.86	8.60	2.52
Net Debt / Equity Ratio	-0.94	-0.94	-1.02	-1.07	-1.75	-1.07
Net Debt / EBITDA Ratio	0.84	0.84	1.91	1.05	0.30	1.11
Net Debt / FCF Ratio	0.81	0.81	1.93	1.05	0.32	1.17
Quick Ratio	6.41	6.41	9.78	5.42	1.50	9.16
Current Ratio	7.07	7.07	10.34	5.84	1.76	9.28
Return on Equity (ROE)	-86.67%	-86.67%	-73.94%	-177.51%	-188.41%	-113.20%
Return on Assets (ROA)	-49.37%	-49.37%	-41.82%	-85.39%	-90.05%	-63.81%
Return on Capital Employed (ROCE)	-112.50%	-112.50%	-53.10%	-101.40%	-593.50%	-96.10%
Earnings Yield	-13.55%	-13.00%	-13.38%	-16.98%	-68.93%	-38.05%
FCF Yield	-	-13.91%	-13.65%	-17.40%	-64.50%	-36.22%
Buyback Yield / Dilution	-79.20%	-79.20%	-105.97%	-336.53%	-89.21%	-124.32%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.